Details for Patent: 8,034,370
✉ Email this page to a colleague
Summary for Patent: 8,034,370
Title: | Ocular implant made by a double extrusion process |
Abstract: | The invention provides biodegradable implants sized for implantation in an ocular region and methods for treating medical conditions of the eye. The implants are formed from a mixture of hydrophilic end and hydrophobic end PLGA, and deliver active agents into an ocular region without a high burst release. |
Inventor(s): | Shiah; Jane-Guo (Irvine, CA), Bhagat; Rahul (Irvine, CA), Blanda; Wendy M. (Tustin, CA), Nivaggioli; Thierry (Los Altos, CA), Peng; Lin (Palo Alto, CA), Chou; David (Palo Alto, CA), Weber; David A. (Danville, CA) |
Assignee: | Allergan, Inc. (Irvine, CA) |
Application Number: | 11/931,954 |
Patent Claim Types: see list of patent claims | Use; Device; |
Drugs Protected by US Patent 8,034,370
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,034,370
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1581193 | ⤷ Subscribe | C300552 | Netherlands | ⤷ Subscribe |
European Patent Office | 1581193 | ⤷ Subscribe | 122012000081 | Germany | ⤷ Subscribe |
European Patent Office | 1581193 | ⤷ Subscribe | SPC/GB12/047 | United Kingdom | ⤷ Subscribe |
Argentina | 051278 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |